SCHEMBL19783073

SCHEMBL19783073

Cc1c(OCCO)cc2sc(Br)nc2c1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
THRB P10828 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PI4KA P42356 1/20 0.33
PIK3CG P48736 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
LOX P28300 1/20 0.33
AOC3 Q16853 1/20 0.33
GAA P10253 1/20 0.32
HSD17B10 Q99714 1/20 0.32
IKBKB O14920 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31
DCK P27707 1/20 0.30
MIF P14174 1/20 0.30
DHPS P49366 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19783026 0.87 PDE10A (0.32) KMT2ATHRBPIK3CDPIK3CAPIK3CB
SCHEMBL19783081 0.87 MKNK2 (0.32) KMT2ATHRBPIK3CDPIK3CAPIK3CB
SCHEMBL19783010 0.80 KMT2A (0.32) KMT2AGAAMIF
SCHEMBL19782602 0.80 HDAC3 (0.35) DCK
SCHEMBL19783435 0.80 CYP2C19 (0.35) DCK
SCHEMBL21395537 0.78 TUBB1 (0.31) TUBB1
SCHEMBL19782421 0.78 LMNA (0.41) KMT2AGAAHSD17B10MIF
SCHEMBL19783068 0.78 MAPT (0.41) KMT2AGAATUBB1
SCHEMBL21379321 0.77 STING1 (0.32)
SCHEMBL19783123 0.76 S1PR4 (0.32) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 KMT2A 2420/4885THRB 845/4885PIK3CD 1304/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 KMT2A 2390/4885THRB 612/4885PIK3CD 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.